Public Company

Alterity Therapeutics Limited

We exist to create an alternate future for people with neurodegenerative diseases. An alternate, healthier life. We’re here to disrupt the trajectory for people living with these debilitating diseases.


Alterity Therapeutics is a clinical-stage biotechnology company focused on broad drug discovery for people living with neurodegenerative diseases. The company’s discovery platform generates patentable chemicals to intervene in disease processes. ATH434 is the company’s lead asset that has potential to treat multiple different forms of Parkinsonian disorders.


Founded 1997
Type Public
Longevity related Yes
Location Melbourne, Victoria, Australia

Latest News


ATHE $1.72 -0.87% $(0.02)